ReviewACS infectious diseases2024

Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection.

Kayhan Ilbeigi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.